No results for ‘’
Sunrest Lifescience Ltd
NSE: SUNREST BSE: 91669
₹33.90
(2.42%)
Mon, 15 Jun 2026, 08:26 am
Market Cap (in Cr)0
PE Ratio21.53
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KSunrest Lifescience Balance Sheet
| Particulars | 2022 | 2023 | 2024 |
|---|---|---|---|
| Interest expense on debt | -591.00K | -2.18M | -3.06M |
| Pretax equity in earnings | 0 | 0 | 0 |
| Equity in earnings | 0 | 0 | 0 |
| Total assets | 167.12M | 251.56M | 586.50M |
| Total current assets | 163.04M | 248.31M | 535.92M |
| Cash and short term investments | 4.50M | 2.90M | 17.38M |
| Cash & equivalents | 4.50M | 2.90M | 4.99M |
| Short term investments | 0 | 0 | 12.39M |
| Total receivables, net | 108.57M | 149.98M | 363.65M |
| Accounts receivable - trade, net | 108.57M | 149.98M | 363.65M |
| Other receivables | 0 | 0 | 0 |
| Total inventory | 39.41M | 50.51M | 127.64M |
| Other current assets, total | 8.05M | 41.68M | 23.04M |
| Total non-current assets | 4.08M | 3.25M | 50.58M |
| Long term investments | 165.00K | 165.00K | 0 |
| Note receivable - long term | — | — | — |
| Investments in unconsolidated subsidiaries | 0 | 0 | 0 |
| Other investments | 165.00K | 165.00K | 0 |
| Net property/plant/equipment | 3.51M | 2.54M | 43.56M |
| Gross property/plant/equipment | — | 5.25M | 51.02M |
| Deferred tax assets | 152.00K | 220.00K | 4.06M |
| Net intangible assets | 0 | 69.00K | 83.00K |
| Goodwill, net | 0 | 0 | 0 |
| Other intangibles, net | 0 | 69.00K | 83.00K |
| Other long term assets, total | 255.00K | 254.00K | 2.88M |
| Short term debt | 1.46M | 26.98M | 63.17M |
| Current portion of LT debt and capital leases | 1.46M | 1.39M | 0 |
| Short term debt excl. current portion of LT debt | 0 | 25.59M | 63.17M |
| Accounts payable | 86.18M | 37.96M | 229.34M |
| Income tax payable | 7.10M | 3.74M | 9.94M |
| Long term debt | 19.97M | 34.62M | 57.33M |
| Long term debt excl. lease liabilities | 19.97M | 34.62M | 57.33M |
| Total equity | 31.14M | 141.85M | 216.29M |
| Shareholders' equity | 31.14M | 141.85M | 163.11M |
| Common equity, total | 31.14M | 141.85M | 163.11M |
| Other common equity | 0 | 0 | 1.20M |
| Total debt | 21.43M | 61.60M | 120.50M |
| Net debt | 16.93M | 58.70M | 103.12M |
| Change in accounts receivable | -15.11M | -41.41M | -41.15M |
| Change in taxes payable | — | — | — |
| Change in accounts payable | 6.86M | -48.23M | 91.77M |
| Change in other assets/liabilities | 10.73M | -47.96M | -29.57M |
| Sale of fixed assets & businesses | 0 | 0 | 2.10M |
| Purchase/sale of investments, net | -165.00K | 0 | 165.00K |
| Sale/maturity of investments | 0 | 0 | 165.00K |
| Purchase of investments | -165.00K | 0 | 0 |
| Other investing cash flow items, total | 0 | 0 | 0 |
| Issuance/retirement of debt, net | -10.95M | 40.16M | -230.00K |
| Issuance/retirement of long term debt | — | — | — |
| Issuance/retirement of short term debt | 0 | 0 | 0 |
| Issuance/retirement of other debt | -10.95M | 40.16M | -230.00K |
| Total cash dividends paid | 0 | 0 | 0 |
| Other financing cash flow items, total | 0 | 0 | 0 |